It is important to note that the reductions in sFRP-3 levels (up to 84%) are similar in magnitude to the 80% elimination of human pancreatic cancers in mice and 86% elimination of human small-cell lung cancers growing in mice (10,11). This evidence concerns the gene FRZB and small cell lung carcinoma.